93 related articles for article (PubMed ID: 9654273)
1. "Personalised" drug therapy could be near.
Larkin M
Lancet; 1998 Jun; 351(9120):1937. PubMed ID: 9654273
[No Abstract] [Full Text] [Related]
2. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
Hiratsuka M; Sasaki T; Mizugaki M
Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
[TBL] [Abstract][Full Text] [Related]
3. Achieving personalized cancer medicine: trials and tribulations.
Powis G
J Investig Med; 2006 Jul; 54(5):235-7. PubMed ID: 16984795
[No Abstract] [Full Text] [Related]
4. [Tailor-made drug therapy].
Ozawa S; Sawada J
Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
[TBL] [Abstract][Full Text] [Related]
5. Getting to personalized cancer medicine: taking out the garbage.
Compton C
Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
[No Abstract] [Full Text] [Related]
6. [Pharmacogenomics genomics approaches to optimizing drug therapy].
Shi J; Chen S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic studies of epilepsy drugs: are we there yet?
Spurr NK
Trends Genet; 2006 May; 22(5):250-2. PubMed ID: 16564110
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacogenetics in pediatric patients.
Husain A; Loehle JA; Hein DW
Pharmacogenomics; 2007 Oct; 8(10):1403-11. PubMed ID: 17979513
[TBL] [Abstract][Full Text] [Related]
10. [II. Pharmacogenetics--the future of modern pharmacology and genetics].
Czerska K; Bal J
Med Wieku Rozwoj; 2004; 8(4 Pt 1):967-91. PubMed ID: 15951616
[TBL] [Abstract][Full Text] [Related]
11. Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.
Watters JW; McLeod HL
Pharmacogenomics; 2002 Nov; 3(6):781-90. PubMed ID: 12437480
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine: challenges in assessing and capturing value in the commercial environment.
Ferrara J
Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770
[No Abstract] [Full Text] [Related]
13. Personalized pharmacotherapy: genotypes, biomarkers, and beyond.
Gurwitz D; Lunshof JE
Clin Pharmacol Ther; 2009 Feb; 85(2):142. PubMed ID: 19005463
[No Abstract] [Full Text] [Related]
14. [Genetic variations affect drug safety and efficacy].
Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
[TBL] [Abstract][Full Text] [Related]
15. Special report: pharmacogenomics of cancer-candidate genes.
Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(5):1-3. PubMed ID: 18080403
[No Abstract] [Full Text] [Related]
16. Overview of the pharmacoeconomics of pharmacogenetics.
Dervieux T; Bala MV
Pharmacogenomics; 2006 Dec; 7(8):1175-84. PubMed ID: 17184205
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.
Tzvetkov M; von Ahsen N
Pathology; 2012 Feb; 44(2):166-80. PubMed ID: 22228255
[TBL] [Abstract][Full Text] [Related]
18. State and federal legislation in personalized medicine.
Raich T; Irwin J
MLO Med Lab Obs; 2007 Aug; 39(8):48. PubMed ID: 17867420
[No Abstract] [Full Text] [Related]
19. What will it take to reap the clinical benefits of pharmacogenomics?
Evans BJ
Food Drug Law J; 2006; 61(4):753-94. PubMed ID: 17180771
[No Abstract] [Full Text] [Related]
20. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
